NCT01611740

Brief Summary

Hospital-acquired infections are common complications in preterm infants. The diagnosis has to be fast and accurate. Indeed, the early identification of a suspected infection is very important, since the early administration of antibiotics lowers the risk of septic shock and improves long term outcome in the infected newborns who survive. Besides, a high specificity in the diagnosis of infection allows for the reduction of inappropriate treatment and thus prevents the emergence of antibiotic resistance. The aim of this study is to develop a computer-assisted diagnosis tool, based on the real time analysis of cardio-respiratory signals, to aid the neonatologist in the diagnosis of infection of the preterm infant, at the bedside.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
525

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2012

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

May 25, 2012

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 5, 2012

Completed
6.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 24, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 24, 2018

Completed
Last Updated

January 24, 2019

Status Verified

January 1, 2019

Enrollment Period

6.7 years

First QC Date

May 25, 2012

Last Update Submit

January 22, 2019

Conditions

Keywords

Preterm infantBacterial infectionDiagnosis of proven or suspected bacterial infection

Outcome Measures

Primary Outcomes (1)

  • Diagnosis of proven or suspected bacterial infection

    The primary outcome will be the efficiency (area under curve, sensitivity, specificity, false-positive and false-negative) of the combined analysis of heart rate and respiratory characteristics for the diagnosis of proven or suspected bacterial infection.

    Within the hospitalisation with an anticipated mean duration of 10 weeks

Secondary Outcomes (2)

  • Inflammation without proven or suspected bacterial infection defined as follows: a 6 hours period with CRP> 5 mg/L not classified as proven or suspected bacterial infection.

    Within the hospitalisation with an anticipated mean duration of 2 to 10 weeks

  • Periods of discomfort defined as at least two EDIN scores above 3 in a 6 hours period

    Within the hospitalisation with an anticipated mean duration of 2 to 10 weeks

Study Arms (1)

Preterm infants

Telemonitoring system prototype developed by INSERM U-642

Procedure: Analysis of the heart rate and respiratory characteristics / Telemonitoring system prototype developed by INSERM U-642

Interventions

Telemonitoring system prototype developed by INSERM U-642 with analysis of : * the variability of the cardiac cycle duration ; * the variability of respiratory cycle amplitude and duration ; * and their relationships.

Preterm infants

Eligibility Criteria

Age24 Weeks - 32 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Preterm birth before \< 32wks and \> 24wks

You may qualify if:

  • preterm birth before \< 32wks and \> 24wks
  • birth weight \> 500g
  • postnatal age\> 3 days
  • postconceptional age \< 34wks
  • parents information and collection of non-opposition

You may not qualify if:

  • malformative syndrome
  • severe neurological injury (IVH grade 4, cavitary periventricular leukomalacia, perinatal asphyxia post ischemia)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

CHU Angers

Angers, Maine Et Loire, 49933, France

Location

CHU de Lille

Lille, 59035, France

Location

CHU de Rennes

Rennes, 35000, France

Location

MeSH Terms

Conditions

Bacterial InfectionsPremature Birth

Condition Hierarchy (Ancestors)

Bacterial Infections and MycosesInfectionsObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Bruno Laviolle, MD, PhD

    Rennes University Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2012

First Posted

June 5, 2012

Study Start

May 1, 2012

Primary Completion

December 24, 2018

Study Completion

December 24, 2018

Last Updated

January 24, 2019

Record last verified: 2019-01

Locations